Before the autoimmune disease was diagnosed, Teresa Kariuki had lost her legs to it. She thought she would die but she lived ...

The nuclear verdict against C.H. Robinson in Texas has been affirmed. The post BREAKING: Texas judge upholds nuclear verdict against C.H. Robinson appeared first on FreightWaves.

The multi-location study aimed to evaluate the efficacy, safety, and tolerability of iptacopan (LNP023) in addition to standard-of-care treatment in lupus.

Biogen’s new drug felzartamab is being tested to treat antibody-mediated rejection, a condition that happens when a kidney transplant patient’s immune system turns on the new organ and attacks it as ...

Oct 16 (Reuters) - Swiss drugmaker Novartis has terminated a mid-stage study testing its drug Fabhalta in patients with a ...

Novartis (NVS) has terminated a mid-stage trial for its oral Factor B inhibitor Fabhalta (iptacopan) in lupus nephritis, an inflammatory condition affecting the kidneys, because of strategic ...

Novartis has ended a mid-stage trial of Fabhalta for lupus nephritis, citing strategic considerations. The clinical-trial registry offered no further explanation and did not indicate whether safety or ...

Droga já era empregada no tratamento de alguns tipos de câncer, e agora tem nova indicação nova, mas custo elevado ainda pode frear acesso à terapia ...

VOL AU-DESSUS d'un champ de brebis - Âgée de 61 ans, elle a écopé de huit mois de prison avec sursis pour avoir dérobé une ...

O Gazyva (obinutuzumabe) recebeu da Anvisa uma nova indicação de uso: o tratamento de adultos que enfrentam lúpus eritematoso ...